- Home
- CRNC vs EBS Comparison
CRNC vs EBS Comparison
Compare CRNC & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNC
- EBS
- Stock Information
- Founded
- CRNC 2020
- EBS 1998
- Country
- CRNC United States
- EBS United States
- Employees
- CRNC N/A
- EBS N/A
- Industry
- CRNC EDP Services
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- CRNC Technology
- EBS Health Care
- Exchange
- CRNC Nasdaq
- EBS Nasdaq
- Market Cap
- CRNC 418.7M
- EBS 359.3M
- IPO Year
- CRNC N/A
- EBS 2006
- Fundamental
- Price
- CRNC $9.21
- EBS $7.16
- Analyst Decision
- CRNC Buy
- EBS Strong Buy
- Analyst Count
- CRNC 6
- EBS 3
- Target Price
- CRNC $10.00
- EBS $14.33
- AVG Volume (30 Days)
- CRNC 2.0M
- EBS 1.4M
- Earning Date
- CRNC 08-06-2025
- EBS 08-06-2025
- Dividend Yield
- CRNC N/A
- EBS N/A
- EPS Growth
- CRNC N/A
- EBS N/A
- EPS
- CRNC N/A
- EBS N/A
- Revenue
- CRNC $254,250,000.00
- EBS $965,400,000.00
- Revenue This Year
- CRNC N/A
- EBS N/A
- Revenue Next Year
- CRNC $8.02
- EBS $16.15
- P/E Ratio
- CRNC N/A
- EBS N/A
- Revenue Growth
- CRNC N/A
- EBS N/A
- 52 Week Low
- CRNC $2.34
- EBS $4.02
- 52 Week High
- CRNC $27.50
- EBS $15.10
- Technical
- Relative Strength Index (RSI)
- CRNC 46.99
- EBS 53.48
- Support Level
- CRNC $8.82
- EBS $6.89
- Resistance Level
- CRNC $10.06
- EBS $7.83
- Average True Range (ATR)
- CRNC 0.58
- EBS 0.37
- MACD
- CRNC -0.05
- EBS -0.00
- Stochastic Oscillator
- CRNC 17.63
- EBS 42.80
About CRNC Cerence Inc.
Cerence Inc is a United States-based software company. It is involved in developing mobility-based solutions for drivers and their cars. The customers include all automobile original equipment manufacturers, or OEMs, or their tier 1 suppliers. The company's revenue is generated by selling software licenses and cloud-connected services. Geographically, it derives a majority of its revenue from the United States and also has a presence in Other Americas; Germany; Other Europe, the Middle East, Africa; Japan, and Other Asia-Pacific.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.